SYNC-T Therapy SV-102

SV-102 · Syncromune, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYNC-T Therapy SV-102, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer [Phase 2]